Clinical Trials on Prostatic Hypertrophy in Ireland
Total 202 results
-
Rhode Island HospitalTerminatedLower Urinary Tract Symptoms | Benign Prostatic HypertrophyUnited States
-
AEterna ZentarisCompletedBenign Prostatic HypertrophyUnited States, Canada
-
Cancer Trials IrelandUnknown
-
Cancer Trials IrelandActive, not recruiting
-
Kira MurphyIrish Research Council; University of Pittsburgh Medical Center; Waterford Instituate...RecruitingExercise | Prostate CancerIreland
-
Cancer Trials IrelandCompleted
-
St. Luke's Hospital, IrelandUnknownProstate CancerIreland, United Kingdom
-
Cancer Trials IrelandJanssen, LPCompleted
-
Cancer Trials IrelandCompletedProstate Cancer | Metastatic CancerIreland
-
Rhode Island HospitalCompletedChildren, Only | Tonsillar Hypertrophy | Adenoid HypertrophyUnited States
-
Guy's and St Thomas' NHS Foundation TrustQueen's University, Belfast; University of Bristol; University of Glasgow; University... and other collaboratorsRecruitingProstate CancerUnited Kingdom
-
Brigham and Women's HospitalCVS CaremarkCompletedDepression | Epilepsy | Cardiovascular Disease | Diabetes | Breast Cancer | Parkinson's Disease | Mental Health Disorder | Prostatic Hypertrophy, BenignUnited States
-
Cancer Trials IrelandCompleted
-
BioProtectRecruitingProstate CancerIreland, Israel, Netherlands, Poland, Portugal
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Reykjavik UniversityThe Icelandic Research Fund; The Icelandic Cancer SocietyCompleted
-
Galway ClinicUnknownMetabolic Syndrome | Prostate Cancer | Intermittent FastingIreland
-
Bristol-Myers SquibbRecruitingCardiomyopathy, HypertrophicUnited States, Australia, Canada, France, Germany, Ireland, Italy, Spain, United Kingdom
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Italy, France, Netherlands, United Kingdom, Poland, Ireland, Spain, Cyprus, Czech Republic, Luxembourg
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningProstate CancerUnited States
-
University Urological Associates Inc.Unknown
-
Scandinavian Prostate Cancer GroupUnknownProstate CancerFinland, Denmark, Iceland, Norway, Sweden
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalCompletedProstate CancerUnited States
-
Brown UniversityTerminated
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningMonitor Adverse EventsUnited States
-
Tampere UniversityCompletedProstate CancerFinland, Ireland, Sweden
-
University of Dublin, Trinity CollegeCompletedObesity | Prostate CancerIreland, United Kingdom
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
Brown UniversityKeitner/Family Therapy Research GrantCompletedBreast Cancer | Sexual Dysfunction | Prostate CancerUnited States
-
Rahul AggarwalNovartisCompletedProstate CancerUnited States
-
Institute of Cancer Research, United KingdomUnknownProstate CancerUnited Kingdom
-
Lihir Medical CentreWithdrawnMalaria | Anaemia | Hyper-reactive Malarial SplenomegalyPapua New Guinea
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Sidekick HealthLandspitali University Hospital; Ljósið Cancer Rehabilitation CenterActive, not recruitingCancer | Colorectal Cancer | Lung Cancer | Prostate CancerIceland
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Bristol-Myers SquibbCompleted
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States